-
Loading metrics
MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk
- Stian Knappskog,
- Liv B. Gansmo,
- Pål Romundstad,
- Merete Bjørnslett,
- Jone Trovik,
- Jan Sommerfelt-Pettersen,
- Erik Løkkevik,
- for the Norwegian Breast Cancer Group trial NBCG VI,
- Rob A. E. M. Tollenaar,
- Caroline Seynaeve
x
- Published: April 30, 2012
- https://doi.org/10.1371/journal.pone.0036263